NCT00129116: 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age |
|
|
| Completed | 2 | 388 | Europe | Hib-MenCY-TT vaccine, Hib-MenC-TT vaccine, Menjugate ®, Infanrix penta ®, DTPa-HBV-IPV vaccine, Infanrix hexa ®, DTPa-HBV-IPV/Hib vaccine | GlaxoSmithKline | Haemophilus Influenzae Type b, Neisseria Meningitidis | 12/03 | 12/03 | | |
NCT00127855: Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine |
|
|
| Completed | 2 | 409 | RoW | Hib-MenCY-TT vaccine (MenHibrix), Meningitec®, ActHIB®, Infanrix® Penta, DTPa-HBV-IPV vaccine, Prevenar®, Mencevax® ACWY, PRP (Polyribosyl Ribitol Phosphate) | GlaxoSmithKline | Haemophilus Influenzae Type b, Neisseria Meningitidis | 02/04 | 02/04 | | |
